The global Preimplantation Genetic Testing market garnered revenue around USD 375.9 million in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of 10.3% throughout the estimate period from 2020 to 2027.
Population suffering from disorders related to the gene is expected to drive the preimplantation genetic testing market. Thus, awareness of people about genetic disorders helps to avoid the risk of having babies with certain genetic disorders.
March of Dimes, a voluntary health group of the US stated about 60%,34% and 6% of babies with serious birth defects were born in developing countries, middle-income countries and rich countries respectively.
Additionally,3.3 million children less than five years die each year from serious birth defects worldwide. But genetic medical services and effective interventions, especially in developing countries, could reduce disability and mortality by up to 70%.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Preimplantation Genetic Testing market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Preimplantation Genetic Testing market growth.
The global Preimplantation Genetic Testing market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Natera, Inc.
CooperSurgical, Inc.
Hoffmann-La Roche AG
Illumina, Inc.
IGENOMIX
Reprogenetics, LLC
Genea Limited
PerkinElmer, Inc.
Genesis Genetics Ltd.
Quest Diagnostics Incorporated
Thermo Fisher Scientific, Inc
Bioarrayn Genetics
Laboratory Corporation of America Holdings
California Pacific Medical Center
Reproductive Health Science Ltd
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
Global Preimplantation Genetic Testing Market, by Procedure
Preimplantation Genetic Diagnosis (PGD)
Preimplantation Genetic Screening (PGS) Beta Thalassemia
Global Preimplantation Genetic Testing Market, by Type
Chromosomal Abnormalities
X-linked Diseases
Embryo Testing
Aneuploidy Screening
HLA Typing
Others
Preimplantation Genetic Testing Market, by Application
Embryo HLA typing for stem cell therapy
IVF Prognosis
Late-Onset Genetic Disorders
Inherited Genetic Disease
Others
Preimplantation Genetic Testing Market, by Technology
Next-Generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-Nucleotide Polymorphism
Preimplantation Genetic Testing Market, by Product and Service
Reagents and Consumables
Instruments
Software and Services
Global Preimplantation Genetic Testing Market, by End User
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs
Research Laboratories & Academic Institutes
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization